utilities

Archive | December, 2015

Latest Blogrss link

New Year’s Resolution: Get involved in dementia research

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

It’s that time of year again where we all start to think about what we can do to be better people. I’ve gone for the classics; I’m going to start at the gym, sort my diet out, and sign up to help beat dementia! I know what you’re thinking, “help beat dementia? Not heard of […]

Pogo sticks, trial results and ‘transmissible Alzheimer’s’ – top 10 headlines from 2015

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

It’s been a busy 12 months for the Alzheimer’s Research UK press team, with dementia seemingly never far from the headlines. We work hard to make sure dementia research and our amazing fundraisers and supporters get the attention they deserve in the media, as well as providing expert comment on scientific developments from around the […]

The Alzheimer’s Research UK Drug Discovery Alliance

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

In February 2015 we launched our £30 million Drug Discovery Alliance. The Drug Discovery Alliance is a network of three Institutes at the Universities of Cambridge and Oxford, and University College London. The Alliance is one of the largest coordinated efforts in the world to find new treatments for dementia and today, we’ve announced the […]

Scientist Focus: Dr John Davis

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

Dr John Davis is the new Chief Scientific Officer at the Alzheimer’s Research UK Oxford Drug Discovery Institute. Tell us a bit about your career path After my PhD and a few years as a post-doctoral researcher in London and the United States, I started work at GlaxoSmithKline – a large pharmaceutical company. There, I […]

Tagged with: ,

Scientist Focus: Prof Paul Whiting

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsFaye Monk

We caught up with the new Chief Scientific Officer of the Alzheimer’s Research UK University College London Drug Discovery Institute. As Chief Scientific Officer, Prof Paul Whiting will drive the progress of the Drug Discovery Institute. He’ll lead the search for promising new ideas that can be developed into the drugs of tomorrow. Tell us […]

Tagged with: ,